000 | 01813 a2200541 4500 | ||
---|---|---|---|
005 | 20250513212547.0 | ||
264 | 0 | _c20000728 | |
008 | 200007s 0 0 eng d | ||
022 | _a1352-0504 | ||
024 | 7 |
_a10.1046/j.1365-2893.2000.00215.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCotler, S J | |
245 | 0 | 0 |
_aPretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C. _h[electronic resource] |
260 |
_bJournal of viral hepatitis _cMay 2000 |
||
300 |
_a211-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aArthralgia _xchemically induced |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aDry Eye Syndromes _xchemically induced |
650 | 0 | 4 | _aEthnicity |
650 | 0 | 4 |
_aFatigue _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeadache _xchemically induced |
650 | 0 | 4 |
_aHepacivirus _xgenetics |
650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferons _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMuscular Diseases _xchemically induced |
650 | 0 | 4 |
_aNausea _xchemically induced |
650 | 0 | 4 |
_aRNA, Viral _xanalysis |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSex Factors |
650 | 0 | 4 | _aViral Load |
650 | 0 | 4 |
_aXerostomia _xchemically induced |
700 | 1 | _aWartelle, C F | |
700 | 1 | _aLarson, A M | |
700 | 1 | _aGretch, D R | |
700 | 1 | _aJensen, D M | |
700 | 1 | _aCarithers, R L | |
773 | 0 |
_tJournal of viral hepatitis _gvol. 7 _gno. 3 _gp. 211-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2893.2000.00215.x _zAvailable from publisher's website |
999 |
_c10800389 _d10800389 |